eClinical Technology

Join The TrialStat Team at SNMMI in Toronto, Canada on June 8th-11th

Read More

Join The TrialStat Team at Digestive Disease Week in Washington, DC, May 20th-21st

Read More

Join The TrialStat Team at the Precision in Clinical Trials Summit in Boston, May 6-7th

Read More

Join The TrialStat Team at the Clinical Outsourcing Group New England Meeting April 23rd – 24th

Read More

A Guide To Selecting The Right Electronic Data Capture (EDC) Technology Vendor


Selecting the Right EDC: A Critical Decision for Clinical Trial Success In the ever-evolving landscape of clinical trials, the choice of an Electronic Data Capture (EDC) technology vendor is more than a mere procedural step; it’s a pivotal decision that can significantly impact the success of your clinical research. Whether you’re embarking on your first…

Read More

Your eClinical Technology Should Adapt To Your Protocol


You should not have to compromise your study design simply because your eClinical Technology does not support your unique study requirements. At TrialStat we do things differently. We believe that you should not have to compromise and to make that a reality, we specialize in Custom Validated Development. Whether it’s a small change in workflow,…

Read More

Streamline Trial Enrollment and Maximize Protocol Compliance with Fully Integrated eConsent


TrialStat’s eConsent platform was designed and developed to solve the most pressing trial enrolment and protocol compliance problems. With a completely customizable workflow, content templates, multimedia capabilities, and multilingual options, Sponsors and CROs have the tools they need to create an immersive eConsent process for trial participants. Our eConsent module is fully integrated with our…

Read More

Anticipating the Future: A Guide to Smart eClinical Technology Investments


The landscape of clinical research is constantly evolving, and businesses need to keep up with the latest technology to remain competitive. However, investing in eClinical technology is not just about finding a solution for current needs, it’s equally important to think ahead and ensure that your technology investment can adapt and scale to meet future…

Read More

Decisions, Decisions! 3 good questions to ask when considering new eClinical Technology.


For 2023, we’re taking our blog in a new direction with more content directly from our team, more detailed information for our readers answering common questions we get, and helpful expert information and ideas you can use. We hope you enjoy this new approach. For this week, we’re covering an introduction (or refresher) to TrialStat…

Read More

Nektar and Collaborators Announce Publication in Blood Advances of Preclinical Data Demonstrating NKTR-255, a Novel Polymer-conjugated Human IL-15, Improves Efficacy of CD19-targeted CAR-T Cell Immunotherapy


— Polymer-conjugated IL-15 (NKTR-255) induced CD8+ T cell and natural killer cell proliferation in vivo — — NKTR-255 enhanced the efficacy of human CD19 CAR-T cells in a xenogeneic lymphoma model — Excerpt from the Press Release: SAN FRANCISCO, Nov. 9, 2022 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) today announced the publication of preclinical data…

Read More